[go: up one dir, main page]

SE9003181D0 - Use of heparin fraction - Google Patents

Use of heparin fraction

Info

Publication number
SE9003181D0
SE9003181D0 SE9003181A SE9003181A SE9003181D0 SE 9003181 D0 SE9003181 D0 SE 9003181D0 SE 9003181 A SE9003181 A SE 9003181A SE 9003181 A SE9003181 A SE 9003181A SE 9003181 D0 SE9003181 D0 SE 9003181D0
Authority
SE
Sweden
Prior art keywords
pct
heparin
medicament
sec
low affinity
Prior art date
Application number
SE9003181A
Other languages
English (en)
Inventor
J Carlson
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE9003181A priority Critical patent/SE9003181D0/sv
Publication of SE9003181D0 publication Critical patent/SE9003181D0/sv
Priority to CA002093357A priority patent/CA2093357A1/en
Priority to EP91917481A priority patent/EP0551354A1/en
Priority to PCT/SE1991/000668 priority patent/WO1992005790A1/en
Priority to JP3516133A priority patent/JPH06502398A/ja
Priority to US08/039,205 priority patent/US5472953A/en
Priority to AU86430/91A priority patent/AU650910B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SE9003181A 1990-10-04 1990-10-04 Use of heparin fraction SE9003181D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9003181A SE9003181D0 (sv) 1990-10-04 1990-10-04 Use of heparin fraction
CA002093357A CA2093357A1 (en) 1990-10-04 1991-10-04 Heparin fraction
EP91917481A EP0551354A1 (en) 1990-10-04 1991-10-04 Use of a heparinfraction
PCT/SE1991/000668 WO1992005790A1 (en) 1990-10-04 1991-10-04 Use of a heparinfraction
JP3516133A JPH06502398A (ja) 1990-10-04 1991-10-04 ヘパリン分画の使用
US08/039,205 US5472953A (en) 1990-10-04 1991-10-04 Fractionated heparin for the therapeutic treatment of malaria
AU86430/91A AU650910B2 (en) 1990-10-04 1991-10-04 Use of a heparinfraction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003181A SE9003181D0 (sv) 1990-10-04 1990-10-04 Use of heparin fraction

Publications (1)

Publication Number Publication Date
SE9003181D0 true SE9003181D0 (sv) 1990-10-04

Family

ID=20380564

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003181A SE9003181D0 (sv) 1990-10-04 1990-10-04 Use of heparin fraction

Country Status (7)

Country Link
US (1) US5472953A (sv)
EP (1) EP0551354A1 (sv)
JP (1) JPH06502398A (sv)
AU (1) AU650910B2 (sv)
CA (1) CA2093357A1 (sv)
SE (1) SE9003181D0 (sv)
WO (1) WO1992005790A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69422496T2 (de) * 1993-09-20 2002-07-11 Ajinomoto Co., Inc. Mittel gegen malaria
SE9703386D0 (sv) * 1997-09-19 1997-09-19 Karolinska Innovations Ab Malaria polypeptides
BR112014014454B1 (pt) 2011-12-19 2021-03-09 Dilafor Ab glicosaminoglicanos não anti-coagulativos compreendendo unidade de dissacarìdo repetida e seus usos médicos
WO2013095215A1 (en) * 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
US12274731B1 (en) 2018-07-12 2025-04-15 Washington University Polybasic antimalarial agents and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134419A (en) * 1981-02-12 1982-08-19 Eisai Co Ltd Stable anticoagulant of blood

Also Published As

Publication number Publication date
AU650910B2 (en) 1994-07-07
CA2093357A1 (en) 1992-04-05
EP0551354A1 (en) 1993-07-21
US5472953A (en) 1995-12-05
JPH06502398A (ja) 1994-03-17
WO1992005790A1 (en) 1992-04-16
AU8643091A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
ATE153346T1 (de) Oxidationsresistente analoga des thrombomodulins
FI946004A0 (sv) Trombinblodfraktion för att användas vid en medicinsk åtgärd
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
IT1248557B (it) Miscele di polisaccaridi di bassi pesi molecolari, procedimento di preparazione e impiego.
MEP36608A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
ES8101381A1 (es) Un procedimiento para la obtencion de un aglutinante para los tejidos a base de proteinas humanas o animales
ATE210147T1 (de) Glycokonjugate von modifizierten camptothecin- derivaten(a- oder b-ring-verknüpfung)
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
ATE239709T1 (de) Racemisches huperzin a
SE9401540D0 (sv) Munhygienkomposition
DE69821498D1 (de) Verwendung von amifostin
IL98917A0 (en) Piperidyl ethers and thioethers and their use as inhibitors of cholesterol biosynthesis
FI885454A0 (fi) Administrationssystem, som laongsamt frigoer substituerade dihydropyridiner.
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
SE9003181D0 (sv) Use of heparin fraction
DE69013011D1 (de) Bcrf1-proteine als inhibitoren von interferon-g(g).
MY103079A (en) New ophtalmological composition of matter
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
ATE134294T1 (de) Zusammensetzung mit psyllium
AP2049A (en) Medicament containing activated antithrombin III
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
AU570552B2 (en) 1,4-dihydropyridine-3-carboxylates and salts thereof
PT1058544E (pt) Inibicao da actividade do tnf
MX9304070A (es) Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol.